International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
作者信息
Silverman S, Curtis J, Saag K, Flahive J, Adachi J, Anderson F, Chapurlat R, Cooper C, Diez-Perez A, Greenspan S, Hooven F, Le Croix A, March L, Netelenbos J C, Nieves J, Pfeilschifter J, Rossini M, Roux C, Siris E, Watts N, Compston J
机构信息
Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA,
出版信息
Osteoporos Int. 2015 Jan;26(1):419-20. doi: 10.1007/s00198-014-2883-2. Epub 2014 Sep 26.
Abstract
摘要
相似文献
1
International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
Osteoporos Int. 2015 Jan;26(1):419-20. doi: 10.1007/s00198-014-2883-2. Epub 2014 Sep 26.
2
Glucocorticoid-induced osteoporosis: an update.
Trends Endocrinol Metab. 2006 May-Jun;17(4):144-9. doi: 10.1016/j.tem.2006.03.009.
3
Glucocorticoid therapy as a significant risk factor for osteoporosis and fractures in an Italian postmenopausal population.
Gynecol Endocrinol. 2013 Jul;29(7):678-82. doi: 10.3109/09513590.2013.788631. Epub 2013 May 2.
4
Prevention and management of steroid-induced osteoporosis.
Br J Hosp Med. 1994;52(2-3):86-9.
5
Teriparatide for glucocorticoid-induced osteoporosis.
J Rheumatol. 2012 Mar;39(3):461-2. doi: 10.3899/jrheum.111629.
6
Animal models for glucocorticoid-induced postmenopausal osteoporosis: An updated review.
Biomed Pharmacother. 2016 Dec;84:438-446. doi: 10.1016/j.biopha.2016.09.045. Epub 2016 Sep 28.
7
Inhaled triamcinolone and chronic obstructive pulmonary disease.
N Engl J Med. 2001 May 17;344(20):1553-4; author reply 1554-6. doi: 10.1056/NEJM200105173442013.
8
[Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
Ugeskr Laeger. 2005 Feb 21;167(8):898-900.
9
Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Eur J Intern Med. 2008 Jan;19(1):51-6. doi: 10.1016/j.ejim.2007.08.005. Epub 2007 Nov 26.
10
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
Osteoporos Int. 2012 Mar;23(3):1083-90. doi: 10.1007/s00198-011-1800-1.
引用本文的文献
1
Mind the bone: a protocol for osteoporosis prophylaxis in patients with thyroid eye disease on intravenous methylprednisolone.
Eye (Lond). 2025 Aug 22. doi: 10.1038/s41433-025-03960-6.
2
Fufang Zhenshu Tiaozhi capsule enhances bone formation and safeguards against glucocorticoid-induced osteoporosis through innovative Mekk2-mediated β-catenin deubiquitination.
J Bone Miner Metab. 2024 Sep;42(5):516-528. doi: 10.1007/s00774-024-01516-4. Epub 2024 May 16.
3
The Dutch multidisciplinary guideline osteoporosis and fracture prevention, taking a local guideline to the international arena.
Arch Osteoporos. 2024 Apr 2;19(1):23. doi: 10.1007/s11657-024-01378-3.
4
Patients with osteoporosis: children of a lesser god.
RMD Open. 2023 Feb;9(1). doi: 10.1136/rmdopen-2022-002973.
5
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial.
J Clin Med. 2022 Dec 30;12(1):292. doi: 10.3390/jcm12010292.
6
Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways.
Front Pharmacol. 2022 Nov 18;13:1007839. doi: 10.3389/fphar.2022.1007839. eCollection 2022.
7
polysaccharide enable suppression of osteoclastic differentiation by exosomes derived from rat mesenchymal stem cells.
Pharm Biol. 2022 Dec;60(1):1303-1316. doi: 10.1080/13880209.2022.2093385.
8
MicroRNA-22 contributes to dexamethasone-induced osteoblast differentiation inhibition and dysfunction through targeting caveolin-3 expression in osteoblastic cells.
Exp Ther Med. 2021 Apr;21(4):336. doi: 10.3892/etm.2021.9767. Epub 2021 Feb 8.
9
Sodium hydrosulfide alleviates dexamethasone-induced cell senescence and dysfunction through targeting the miR-22/sirt1 pathway in osteoblastic MC3T3-E1 cells.
Exp Ther Med. 2021 Mar;21(3):238. doi: 10.3892/etm.2021.9669. Epub 2021 Jan 21.
10
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.
Drugs. 2019 Jul;79(10):1065-1087. doi: 10.1007/s40265-019-01145-6.
Zotero 插件